Fig. 2From: HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched studyComparison of survival curves for progression-free survival (PFS) among HIFU group, BSC group, and PC group (p < 0.001)Back to article page